Grohar, Patrick J <br/><br/>
Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing Sarcoma.  [electronic resource] 

 -  Cell reports  Jan 2016 
 - 598-610 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2211-1247 
<br/><br/><label>Standard No.: </label>10.1016/j.celrep.2015.12.063  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Base Sequence<br/>Binding Sites<br/>Calmodulin-Binding Proteins--antagonists & inhibitors<br/>Cell Line, Tumor<br/>Cell Survival<br/>Exons<br/>Gene Expression Regulation, Neoplastic<br/>Heterogeneous-Nuclear Ribonucleoprotein Group F-H--antagonists & inhibitors<br/>Humans<br/>Microfilament Proteins--antagonists & inhibitors<br/>Oncogene Proteins, Fusion--antagonists & inhibitors<br/>Phosphoproteins--antagonists & inhibitors<br/>Proto-Oncogene Protein c-fli-1--antagonists & inhibitors<br/>RNA Interference<br/>RNA Precursors--metabolism<br/>RNA Splicing<br/>RNA Splicing Factors<br/>RNA, Small Interfering--metabolism<br/>RNA-Binding Protein EWS--antagonists & inhibitors<br/>RNA-Binding Proteins--antagonists & inhibitors<br/>Receptors, Cytoplasmic and Nuclear--antagonists & inhibitors<br/>Ribonucleoprotein, U2 Small Nuclear--antagonists & inhibitors<br/>Sarcoma, Ewing--pathology<br/>Trans-Activators<br/>Transcription Factors--antagonists & inhibitors